AZELASTINE CHLORHYDRATE/FLUTICASONE PROPIONATE VIATRIS 137 micrograms/50 micrograms, suspension for spraying nasal bottle, 23 g
Active ingredients: Azelastine, Azelastine hydrochloride, Fluticasone propionate
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for sprayingbottle, 23 gnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AZELASTINE CHLORHYDRATE/FLUTICASONE PROPIONATE VIATRIS 137 microgrammes/50 microgrammes, suspension pour pulvérisation nasale
- Pharmaceutical form
- suspension pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) en verre brun de 23 g aavec pompe doseuse avec applicateur nasal polypropylène.
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61082446CIP73027138CIP133400930271384Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AZÉLASTINEsuspension | 137 microgrammes · une pulvérisation (0,14 g) | SA |
| PROPIONATE DE FLUTICASONEsuspension | 50 microgrammes · une pulvérisation (0,14 g) | SA |
| AZÉLASTINEsuspension | 125 microgrammes · une pulvérisation (0,14 g) | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.